Article
The Role of the Kinase Inhibitors in Thyroid Cancers
11 May 2022
Abstract excerpt
Thyroid cancer is the most common endocrine malignancy, accounting for about 3% of all cancer cases each year worldwide with increasing incidence, but with the mortality remaining stable at low levels. This contradiction is due to overdiagnosis of indolent neoplasms identified by neck ultrasound screening that would remain otherwise asymptomatic. Differentiated thyroid carcinomas (DTCs) are almost curable for 95%...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
